Pyxis Oncology, Inc. Annual Operating Income (Loss) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Pyxis Oncology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
  • Pyxis Oncology, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$23.8M, a 6.31% increase year-over-year.
  • Pyxis Oncology, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$67.2M, a 34.4% increase year-over-year.
  • Pyxis Oncology, Inc. annual Operating Income (Loss) for 2023 was -$82.2M, a 33.4% increase from 2022.
  • Pyxis Oncology, Inc. annual Operating Income (Loss) for 2022 was -$123M, a 77.1% decline from 2021.
  • Pyxis Oncology, Inc. annual Operating Income (Loss) for 2021 was -$69.7M, a 441% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$82.2M +$41.3M +33.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$123M -$53.8M -77.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$69.7M -$56.8M -441% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 -$12.9M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.